We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
VistaGen Therapeutics Inc | NASDAQ:VTGN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.41 | 3.58 | 4.95 | 10 | 09:00:39 |
Nevada
|
|
20-5093315
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification Number)
|
|
|
|
VistaGen Therapeutics, Inc.
343 Allerton Avenue
South San Francisco, California 94080
(650) 577-3600
|
|
Shawn K. Singh
Chief Executive Officer
VistaGen Therapeutics, Inc.
343 Allerton Avenue
South San Francisco, California 94080
(650) 577-3600
|
(Address, including zip code, and telephone number,
including area code of Registrant’s principal executive
offices),
|
|
(Name, address, including zip code, and telephone
number,
including area code, of agent for service)
|
Large accelerated filer [ ]
|
|
Accelerated filer [ ]
|
Non-accelerated filer [ ]
|
|
Smaller reporting company [X]
|
|
|
Emerging growth company [ ]
|
*
|
To be filed, if necessary, by incorporation by reference pursuant
to a Current Report on Form 8-K in connection with an offering
of securities.
|
**
|
Previously filed as an exhibit to the Company’s Registration
Statement on Form S-3, filed on September 30, 2019.
|
|
VistaGen Therapeutics, Inc..
|
||
|
|
|
|
|
By:
|
/s/
Shawn K. Singh
|
|
|
|
Shawn K. Singh, J.D.
|
|
|
|
Chief Executive Officer
|
Signature
|
|
Title
|
|
Date
|
|
|
|
||
/s/
*
Shawn K. Singh, JD
|
|
Chief Executive Officer, and Director
(Principal Executive Officer)
|
|
October 3, 2019
|
|
|
|
||
/s/
*
Jerrold D. Dotson
|
|
Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)
|
|
October 3, 2019
|
|
|
|
||
/s/
*
H. Ralph Snodgrass, Ph.D
|
|
President, Chief Scientific Officer and Director
|
|
October 3, 2019
|
|
|
|
||
/s/
*
Jon S. Saxe
|
|
Chairman of the Board of Directors
|
|
October 3, 2019
|
|
|
|
||
/s/
*
Brian J. Underdown, Ph. D
|
|
Director
|
|
October 3, 2019
|
|
|
|
|
|
/s/
*
Jerry B. Gin, Ph.D.
|
|
Director
|
|
October 3, 2019
|
|
|
|
|
|
/s/
*
Ann M. Cunningham
|
|
Director
|
|
October 3, 2019
|
1 Year VistaGen Therapeutics Chart |
1 Month VistaGen Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions